LOW BMI IS AN INDEPENDENT DETERMINANT OF VACCINE NON-RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN INDIA: ANALYSIS OF SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION

Remicade (infliximab) - J&J

Vaxzevria (ChAdOx1-S recombinant) - University of Oxford, Emergent Biosolutions, Jenner Institute, Barinthus Bio, AstraZeneca

Covaxin (BBV152 COVID Vaccine) - Bharat Biotech, Indian Council of Medical Research, Ocugen

https://eposters.ddw.org/ddw/2025/ddw-2025/4154879/serre-yu.wong.low.bmi.is.an.independent.determinant.of.vaccine.non-response.in.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Ace_id%3D2855%2Aot_id%3D31400%2Amarker%3D5698

Serre-Yu Wong 1; Hunter R Moran 1; Georgia Elgood-Hunt 2; Lucas Stolle 3; Elisabeth Giselbrecht 1; Judith Wellens 4; Vineet Ahuja 5; Shubi Virmani 5; Mukesh Kumar 5; Bipul Kumar 5; Saurabh Kedia 5; Usha Dutta 6; Saroj Sinha 6; Vishal Sharma 6; Jayanta Samanta 6; Jimil Shah 6; Singh Kumar Anupam 6; Harmandeep Kaur 6; Jean Frederic Colombel 1; Craig Thompson 3; Jack Jyoti Satsangi 7

Mar 8, 2025